RegisterLogin

JPH203

CAT: 0498-bs-82871C-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0498-bs-82871C-01Size:5 mg
Selected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Background
Selective L-type amino acid transporter 1 inhibitor (LAT1 or SLC7A5; IC50 = 140 nM for 14C-leucine uptake in S2-hLAT1 cells, and 60 nM for HT29 human colon adenocarcinoma cells: growth inhibition IC50’s = 16.4 µM and 4.1 µM respectively for S2 and HT29 cells) .1 Also active in HT-29 mouse xenograft models. JPH203 is active in a variety of cancer models and has progressed to clinical trials.2 It sensitized A549 and MIA Paca-2 cells to radiation by enhancing cellular senescence via mTOR downregulation3 and sensitized EGFR-expressing cancer cell lines to gefitinib therapy4. JPH203 treatment of non-small cell lung cancer cells led to downregulation of PD-L1 suggesting that LAT1 inhibition may help overcome the immune suppressive tumor microenvironment.5
Conjugation
Unconjugated
Buffer
Pale orange/yellow solid
Storage Conditions
-20°C

Related Products

CatalogName
bs-104228P-01Recombinant Human JPH3/JP-3 Protein, N-His

Alternative Products

CatalogName
MBS3600188-01JPH203
MBS3844890-01JPH203
MBS131652-01JPH203
BUP04834-01JPH203
M10188-01JPH203
TQ0081-01JPH203
abx283350-01JPH203
MBS5764338JPH203
HY-100868JPH203
BUP05574-01JPH203 dihydrochloride

Popular Products